A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Open-label Multicenter Phase 1 Study of TBI 302 as Second-Line Therapy in Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Branched-chain Amino Acid Supplementation for Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC
- Status
- RECRUITING
- Phase
- PHASE2
TCR-Redirected T Cells Therapy in Patient With HBV Related HCC
- Status
- UNKNOWN
- Phase
- PHASE1
RFA vs. SBRT for Small HCC
- Status
- UNKNOWN
- Phase
- PHASE3
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
- Status
- UNKNOWN
- Phase
- N/A
Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Radioembolization of Primary and Secondary Liver Malignancies and The Effect On The Immune System
- Status
- TERMINATED
- Phase
- NA
ET1402L1-ARTEMIS™2 T Cells in Alpha Fetoprotein (AFP) Expressing Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Chimeric Antigen Receptor T Cells Targeting Glypican-3
- Status
- COMPLETED
- Phase
- PHASE1
By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation
- Status
- UNKNOWN
- Phase
- N/A
Pretreatment Lymphocyte Monocyte Ratio on Outcome HCC Patients
- Status
- UNKNOWN
- Phase
- N/A
HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Toripalimab in Combination With Lenvatinib as Neoadjuvant Therapy in Resectable Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
- Status
- COMPLETED
- Phase
- PHASE3
Toripalimab or Placebo as Adjuvant Therapy in Hepatocellular Carcinoma After Radical Resection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Stereotactic Body Radiation Therapy Combined With Anti-PD-1 Antibody in Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis
- Status
- UNKNOWN
- Phase
- NA
Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study)
- Status
- COMPLETED
- Phase
- N/A